Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.

Carmen ScheibenbogenMadlen LoebelHelma FreitagAnne KruegerSandra BauerMichaela AntelmannWolfram DoehnerNadja ScherbakovHarald HeideckePetra ReinkeHans-Dieter VolkPatricia Grabowski

Published in: PloS one (2018)

IA can remove autoantibodies against ß2 adrenergic receptor and lead to clinical improvement. B cell phenotyping provides evidence for an effect of IA on memory B cell development. Data from our pilot trial warrants further studies in CFS/ME.

Keyphrases

systemic lupus erythematosus
high throughput
electronic health record
working memory
sleep quality
case control
drug induced